Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.

作者信息

Jakobs C, Michael T, Jaeger E, Jaeken J, Gibson K M

出版信息

Eur J Pediatr. 1992 Jun;151(6):466. doi: 10.1007/BF01959366.

DOI:10.1007/BF01959366

PMID:1628679

Abstract

摘要

相似文献

Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.

Eur J Pediatr. 1992 Jun;151(6):466. doi: 10.1007/BF01959366.

Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

J Inherit Metab Dis. 1995;18(2):143-6. doi: 10.1007/BF00711750.

4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy.

J Inherit Metab Dis. 1993;16(3):520-2. doi: 10.1007/BF00711670.

[4-Hydroxybutyric aciduria].

Ryoikibetsu Shokogun Shirizu. 1998(18 Pt 1):250-1.

Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency.

Lancet. 1989 Nov 4;2(8671):1105-6. doi: 10.1016/s0140-6736(89)91126-4.

Clinical correlation of dysequilibrium syndrome and 4-hydroxybutyric aciduria.

J Inherit Metab Dis. 1985;8(2):58. doi: 10.1007/BF01801664.

4-Hydroxybutyric aciduria: application of a fluorometric assay to the determination of succinic semialdehyde dehydrogenase activity in extracts of cultured human lymphoblasts.

Clin Chim Acta. 1991 Feb 15;196(2-3):219-21. doi: 10.1016/0009-8981(91)90076-o.

Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).

J Pharmacol Exp Ther. 2002 Jul;302(1):180-7. doi: 10.1124/jpet.302.1.180.

Succinic semialdehyde dehydrogenase deficiency associated with combined 4-hydroxybutyric and dicarboxylic acidurias: potential for clinical misdiagnosis based on urinary organic acid profiling.

J Pediatr. 1989 Apr;114(4 Pt 1):607-10. doi: 10.1016/s0022-3476(89)80706-1.

The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.

Pediatrics. 1997 Apr;99(4):567-74. doi: 10.1542/peds.99.4.567.

引用本文的文献

Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency.

Mol Genet Metab. 2024 May;142(1):108363. doi: 10.1016/j.ymgme.2024.108363. Epub 2024 Mar 4.

Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

J Inherit Metab Dis. 2013 May;36(3):401-10. doi: 10.1007/s10545-012-9499-5. Epub 2012 Jun 28.

Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (gamma-vinyl-GABA).

J Inherit Metab Dis. 1996;19(3):313-8. doi: 10.1007/BF01799261.

Inherited disorders of GABA metabolism.

J Inherit Metab Dis. 1993;16(4):704-15. doi: 10.1007/BF00711902.

A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.

Drug Saf. 1994 May;10(5):395-405. doi: 10.2165/00002018-199410050-00004.

4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy.

J Inherit Metab Dis. 1993;16(3):520-2. doi: 10.1007/BF00711670.

Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

J Inherit Metab Dis. 1995;18(2):143-6. doi: 10.1007/BF00711750.

本文引用的文献

4-Hydroxybutyric aciduria: a new inborn error of metabolism. II. Biochemical findings.

J Inherit Metab Dis. 1984;7 Suppl 1:92-4.

4-Hydroxybutyric aciduria: a new inborn error of metabolism. I. Clinical review.

J Inherit Metab Dis. 1984;7 Suppl 1:90-2.

Gammahydroxybutyrate: an endogenous regulator of energy metabolism.

Neurosci Biobehav Rev. 1989 Winter;13(4):187-98. doi: 10.1016/s0149-7634(89)80053-3.

Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency.

Lancet. 1989 Nov 4;2(8671):1105-6. doi: 10.1016/s0140-6736(89)91126-4.

Vigabatrin in GABA metabolism disorders.

Lancet. 1989 May 13;1(8646):1074. doi: 10.1016/s0140-6736(89)92466-5.

The first adult case with 4-hydroxybutyric aciduria.

J Inherit Metab Dis. 1990;13(3):341-4. doi: 10.1007/BF01799390.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验